138 related articles for article (PubMed ID: 3455878)
1. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
[TBL] [Abstract][Full Text] [Related]
2. Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.
Vánky F; Willems J; Kreicbergs A; Aparisi T; Andréen M; Broström LA; Nilsonne U; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):11-6. PubMed ID: 6605799
[TBL] [Abstract][Full Text] [Related]
3. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
[TBL] [Abstract][Full Text] [Related]
4. Lysis of autologous tumor cells by blood lymphocytes activated in autologous mixed lymphocyte tumor cell culture--no correlation with the postsurgical clinical course.
Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A
Cancer Immunol Immunother; 1987; 24(2):180-3. PubMed ID: 2950997
[TBL] [Abstract][Full Text] [Related]
5. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients.
Uchida A; Kariya Y; Okamoto N; Sugie K; Fujimoto T; Yagita M
J Natl Cancer Inst; 1990 Nov; 82(21):1697-701. PubMed ID: 2231757
[TBL] [Abstract][Full Text] [Related]
6. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
7. The immune-status in patients with bone and soft-tissue sarcomas.
Kotz R; Rella W; Salzer M
Recent Results Cancer Res; 1976; (54):197-205. PubMed ID: 1070721
[TBL] [Abstract][Full Text] [Related]
8. [Detection of suppressor lymphocytes in the blood of oncological patients by using a 3-component lymphocyte mixed culture].
Govallo VI
Vopr Onkol; 1981; 27(9):30-6. PubMed ID: 6457445
[TBL] [Abstract][Full Text] [Related]
9. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.
Vose BM; Vanky F; Klein E
Int J Cancer; 1977 Oct; 20(4):512-9. PubMed ID: 914394
[TBL] [Abstract][Full Text] [Related]
11. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Vánky F; Klein E
Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific immunity in sarcoma patients.
Rella W; Kotz R; Arbes H; Leber H
Oncology; 1977; 34(5):219-23. PubMed ID: 144262
[TBL] [Abstract][Full Text] [Related]
13. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of T lymphocytes propagated from human lung carcinomas.
Kurnick JT; Kradin RL; Blumberg R; Schneeberger EE; Boyle LA
Clin Immunol Immunopathol; 1986 Mar; 38(3):367-80. PubMed ID: 3080265
[TBL] [Abstract][Full Text] [Related]
15. Importance of MHC antigen expression on solid tumors in the in vitro interaction with autologous blood lymphocytes.
Vánky F; Stuber G; Willems J; Sjöwall K; Larsson B; Böök K; Ivert T; Péterffy A; Klein E
Cancer Immunol Immunother; 1988; 27(3):213-22. PubMed ID: 2972365
[TBL] [Abstract][Full Text] [Related]
16. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of chemioresistant human tumor explants to lysis by activated and nonactivated autological lymphocytes: a pilot study.
Berezhnaya NM; Vinnichuk UD; Konovalenko VF; Vorobjova LI; Belova OB; Proskurnia LA
Exp Oncol; 2005 Dec; 27(4):303-7. PubMed ID: 16404351
[TBL] [Abstract][Full Text] [Related]
18. Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).
Vánky F; Klein E; Stjernswärd J; Rodriguez L; Péterffy A; Steiner L; Nilsonne U
Int J Cancer; 1978 Dec; 22(6):679-86. PubMed ID: 309867
[TBL] [Abstract][Full Text] [Related]
19. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
20. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients.
Chretien PB; Crowder WL; Gertner HR; Sample WF; Catalona WJ
Surg Gynecol Obstet; 1973 Mar; 136(3):380-4. PubMed ID: 4688801
[No Abstract] [Full Text] [Related]
[Next] [New Search]
